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Summary
Pneumocystis pneumonia (PCP) is an opportunistic 
fungal infection that is usually seen in 
immunocompromised patients, especially those with 
HIV, malignancies, organ transplants and on drug 
therapies like chemotherapy and steroids. PCP has 
subacute presentation in patients with AIDS which if 
left untreated gets worse and is a significant cause of 
morbidity and mortality. Here we present a case of PCP 
went undiagnosed, partially due to the patient being 
unaware of his HIV positive status and partially because 
no organism could be found under the microscope.
Background
Pneumocystis pneumonia (PCP) is caused by the 
fungus Pneumocystis jirovecii. Although the advent 
of highly active antiretroviral therapy for patients 
with HIV has led to a decrease in cases of PCP, it 
remains the most common opportunistic infection 
in patients with AIDS.1 Clinically, PCP presents as 
a subacute process with symptoms being gradual in 
onset. Pneumocystis cannot be cultured; therefore, 
definitively diagnosing PCP depends on micro-
scopic examination of tissues or fluids from the 
lungs.2 Diagnosing PCP can be a hard task because 
in comparison with other pulmonary pathologies, 
PCP has no unique presentation that would allow 
a clinician to differentiate and diagnose it. Here 
we present a case of PCP in which all the speci-
mens failed to show any form of the organism and 
later on lung biopsy diagnosed PCP, and the patient 
was then treated for it and got better and turned out 
HIV positive.
caSe preSentation
A 50-year-old man presented to the pulmon-
ology clinic with complaints of fever, weight loss 
and productive cough since the last 1 month. His 
fever was low grade and spiked in the evenings, 
reaching a maximum of 38°C. He had previously 
taken several antibiotics without any relief and 
most recently had finished a course of amoxicillin 
for 7 days. He had noticed a significant decrease in 
appetite in the immediate past and had lost approx-
imately 8–10 kg. He had placement of permanent 
pacemaker 10 years ago due to sick sinus syndrome. 
With a history of carcinoma of the stomach, he 
had received chemotherapy and undergone partial 
gastrectomy 5 years ago. A few months ago, he had 
been hospitalised due to upper gastrointestinal 
bleeding secondary to gastric ulcers. Significantly, 
he had received multiple blood transfusions in the 
past. There was no known tuberculosis contact 
history and no extramarital affairs. On exam-
ination, he was a thin, lean young male with no 
evident respiratory distress. His blood pressure was 
103/68 mm Hg, his pulse was 90 beats/min, respi-
ratory rate was 14 breaths/min and his weight was 
43 kg. On auscultation, normal vesicular breathing 
was heard with no added sounds. His oxygen satu-
ration was consistent at 99% on room air.
inveStigationS
His chest X-ray showed bilateral diffuse intersti-
tial prominence with nodular infiltrates (figure 1). 
CT scan showed patchy area of ground glass with 
relative sparing of the apices and intralobular 
septal thickening with some nodular infiltrates in 
bilateral lung fields (figure 2). Complete blood 
count was unremarkable. He was unable to expec-
torate sputum, so bronchoscopy was advised but 
the patient refused for any intervention. Consid-
ering the high TB burden in Pakistan, he was started 
on empiric antituberculous therapy (ATT) but 
despite being on ATT for a month no improvement 
was noted. Patient returned to the clinic with wors-
ening symptoms. Fever was persisting daily during 
the night. Chest X-ray was repeated and it showed 
alveolar infiltrates on bilateral perihilar and lower 
zones (figure 3).
The patient eventually agreed for bronchoscopy. 
On bronchoscopy, there were normal airways with 
normal mucosa. Bronchial washings were taken 
from lower lobes bilaterally and specimens were 
sent for microbiology and cultures and cytology. His 
blood culture showed no growth of any organism. 
Acid fast bacilli smear and culture were both nega-
tive. Nocardia, fungus smear and culture were also 
negative. Gram stain showed only rare pus cells. 
PCP and GeneXpert/MTB-RIF were also negative. 
Cytology also ruled out malignancy.
Despite being on ATT for 2 months, no improve-
ment was noted. The patient was then referred to 
the cardiothoracic surgeon for lung biopsy. Right 
open lung biopsy was taken from middle and lower 
lobes. Microscopy of the specimen with the silver 
stain, the periodic acid-Schiff-diastase stain and 
immunofluorescent staining did not reveal anything 
of significance; no evidence of granulomatous 
inflammation or malignancy was seen. However, 
within the alveolar spaces, pink frothy protein-
aceous exudate was visualised (figure 4), and thus 
the query of PCP was raised by the histopathologist. 
Blood was tested for HIV the next day which came 
back reactive. Given the overall picture, a presump-
tive diagnosis of PCP was made and therapy was 
started.
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differential diagnoSiS
1. Tuberculosis.
2. Fungal infection.
3. Metastatic carcinoma with lymphangitis carcinomatosis.
4. Nocardia.
5. Sarcoidosis.
treatment
Patient was started on Septran double strength. This contains 
sulfamethoxazole (800 mg) and trimethoprim (160 mg). No 
allergic reactions were evident and the patient tolerated the 
therapy well for a total of 21 days.
outcome and follow-up
After 1 week of treatment, the patient started getting better. 
The patient noted improvement in breathing and became 
afebrile. Chest X-ray also showed signs of betterment and even-
tually he recovered. The patient has since been in good health 
and has been undergoing routine follow-ups for the last 2 years 
under infectious disease (for HIV) and gastroenterology.
diScuSSion
Pneumocystis is currently classified as a fungus but does not 
respond to antifungal therapy and cannot be grown on culture in 
a laboratory. The common symptoms of PCP include low-grade 
fever (80%–100%), productive cough (95%), dyspnoea (95%) 
and shortness of breath.3 4 Clinically diagnosing PCP is diffi-
cult even for experienced physicians because the manifestations 
are very non-specific.5 Chest X-rays are normal in 25% of all 
initial cases of PCP and CT scans are inconclusive for the type of 
abnormality. The radiological findings can be atypical, although 
most commonly visualised are bilateral interstitial infiltrates.6
figure 1 Chest X-ray showing bilateral diffuse interstitial prominence 
with nodular infiltrates.
figure 2 CT scan showing septal thickening with nodular infiltrates in 
bilateral lung fields.
figure 3 Chest X-ray showing bilateral perihilar and lower zones 
alveolar infiltrates.
figure 4 Histopathology of lung tissue showing alveolar spaces filled 
with pink frothy proteinaceous exudate (H&E staining).
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In diagnosing PCP microscopically, the samples obtained can 
be those of sputum obtained through expectorated induction 
(30%–90% specificity), from alveoli through bronchoalveolar 
lavage (90%–95% specificity) or most invasively from a lung 
biopsy (95%–100% specificity).7 The stains most commonly 
used to view the pneumocystis are Gomori-methenamine silver 
(more commonly known as silver stain), the Gram-Weigert stain 
and the Wright-Giemsa stain. However, immunofluorescent 
staining using fluorescent-labelled monoclonal antibodies repre-
sent the gold standard for PCP diagnosis being more sensitive 
than the aforementioned general stains. Raised levels of lactate 
dehydrogenase are also seen in PCP but they are more indicative 
of lung tissue damage than PCP.8 Serum 1,3-beta-d-glucan (BDG) 
levels have also been seen to increase in PCP infection.9 Serum 
BDG showed excellent sensitivity and very good specificity in 
the diagnosis of PCP.10 In order to establish an early diagnosis, 
BDG is helpful where patients are not able to produce sputum 
or refused to peruse for invasive testing like bronchoscopy as in 
our case but unfortunately this test was not available at the time 
of our patient presentation.
The diagnosis of PCP requires a high clinical suspicion from 
the consultant to order the relevant tests. In our case, not 
knowing the existence of HIV in the patient and not enquiring 
about it to avoid offending the patient’s religious beliefs further 
complicated the scenario. Three months elapsed before our 
patient was diagnosed and his weight in the meantime fell to 
37.5 kg. Fortunately, in our case, the patient survived. Our case 
shows the importance of an open mind from a clinician’s point 
of view and how it is always necessary to consider all possibilities 
regardless of how improbable they may seem. It also shows the 
normal process and time taken to diagnose an atypical disease. 
Upon enquiry later, it was discovered that a cousin of the patient 
was HIV positive and had donated blood to the patient in the 
past. If the patient had known to be HIV positive, he would 
have been on prophylactic treatment and could have avoided 
contracting PCP.
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learning points
 ► Atypical pneumonia should be considered when no 
improvement is seen with normal antibiotics.
 ► Immunofluorescent staining should be used in addition to 
regular stains when pneumocystis is suspected.
 ► Definitive signs may not always be present; a clinician has to 
work up a holistic picture of a disease process.
 ► Beta-d-glucan can be helpful in such case scenarios where 
patient refuses for invasive testing like bronchoscopy.
